Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gen İlaç Ve Sağlik Ürünleri A.ş.

Clinical trials sponsored by Gen İlaç Ve Sağlik Ürünleri A.ş., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to boost brain energy in Parkinson's patients Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New drug aims to boost brain energy in Parkinson's patients

Disease control Recruiting now

This study tests whether a new drug called SUL-238 can improve energy production in brain cells of people with early, untreated Parkinson's disease. Forty-five participants will take either a low or high dose of SUL-238 or a placebo daily for 28 days. Researchers will use a speci…

Phase 2 • Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. • Aim: Disease control

Last updated Aug 19, 2026 00:00 UTC